Home
About Rico
Company Profile
Development History
Corporate culture
Company environment
Company Honors
News
Company News
Industry Trends
Services
Cooperation
Partner
Contact Us
Policy
Join us
Social Recruitment
Campus Recruitment
CN
EN
Imported healthy food
Imported medicines
Imported medical devices
Zhang Shaohui
President Master of Science from Shenyang Pharmaceutical University, EMBA Professor-level Senior Engineer National Licensed Pharmacist Possesses 8 years of experience in pharmaceutical R&D and scientific research management at a large, state-owned pharmaceutical enterprise in China; and 23 years of mid-to-high-level management experience at a major Japanese multinational corporation. Has worked across multiple areas including pharmaceutical R&D, drug registration, pharmacovigilance, strategic management, supply chain management, and trademark and patent management. Previously participated in the development, registration, and introduction of numerous pharmaceutical products.
Li Ping
Executive President Graduated from the Bethune Medical University Medical Japanese Major For nearly 20 years, I have been working at a Japanese-funded enterprise in the pharmaceutical registration field, participating in and successfully completing dozens of registration applications for both domestically produced and imported drugs, as well as applications for international multi-center clinical trials. I have undergone several on-site inspections—covering domestic manufacturing sites, clinical trial sites, and overseas manufacturing sites—and have completed numerous registrations of active pharmaceutical ingredients, excipients, and packaging materials, as well as medical device import registrations.
Wen He
Vice President Head of Development and Registration Graduated from Zhejiang University Biomedical Engineering For over 30 years, I have served as an executive at a Japanese multinational pharmaceutical company, responsible for the clinical development and regulatory registration of Japanese pharmaceutical products in China. I have a deep understanding of Chinese regulations and drug development requirements, as well as familiarity with the R&D patterns specific to Japan. I possess extensive experience in the introduction and development of pharmaceuticals, medical devices, health supplements, and disinfectant products.
Diamond
Vice President Head of International Business Chief Representative in Japan Graduated from Osaka University of Education, Japan Master of Economics (Japanese Ministry of Education Government-Funded International Student) Japanese Permanent Resident Card (Chinese Nationality) Since 2001, I have been engaged in product marketing, project planning, and development activities in Japan for nearly 20 years. I previously worked at Toshiba Corporation in Japan and successfully led the development of several major international projects. I have a deep understanding of the Japanese pharmaceutical industry and possess exceptional information-gathering and analytical skills, as well as an extensive network of industry contacts.
Anxi Jifu
Senior Medical Advisor Tokyo Representative Office Graduated from the Faculty of Science, Gakushuin University, Japan Chemistry Major Joined Sankyo Co., Ltd. (later renamed Daiichi Sankyo Co., Ltd.) in Japan; served as a medical representative in Japan for 7 years, headed the company’s export business for 6 years, and worked as a product manager in Asia, the Middle East, and Central and South America for 23 years, during which time the cumulative sales of the hypertension medications he/she was responsible for reached 29 billion yen. Possesses extensive experience in pharmaceutical product development.
Li Mei
Senior Advisor Graduated from Peking University School of Medicine Chief Physician, Senior Drug Review Expert He previously served as an Associate Researcher at the Institute of Medical Biotechnology, Chinese Academy of Medical Sciences, and as Director of the Development Division in the Office of Scientific Research. For more than ten years, he worked at the Center for Drug Evaluation (CDE) of the National Medical Products Administration, where he held the position of Director (Minister) of the Chemical Drugs and Biological Products Division. He was also a key drafter of China’s “Regulations on the Review of Over-the-Counter Drugs.”